Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017
Coccidioidomycosis skin testing appears to be uncommon, based on US health insurance claims data. Patient demographic features were consistent with the approval of the test for adults, but few patients had previous coccidioidomycosis diagnosis codes supporting its use for detecting delayed-type hype...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Centers for Disease Control and Prevention
2020-03-01
|
Series: | Emerging Infectious Diseases |
Subjects: | |
Online Access: | https://wwwnc.cdc.gov/eid/article/26/3/19-0798_article |
_version_ | 1828371125320548352 |
---|---|
author | Kaitlin Benedict Orion Z. McCotter Brendan R. Jackson |
author_facet | Kaitlin Benedict Orion Z. McCotter Brendan R. Jackson |
author_sort | Kaitlin Benedict |
collection | DOAJ |
description | Coccidioidomycosis skin testing appears to be uncommon, based on US health insurance claims data. Patient demographic features were consistent with the approval of the test for adults, but few patients had previous coccidioidomycosis diagnosis codes supporting its use for detecting delayed-type hypersensitivity in those with a history of pulmonary coccidioidomycosis. |
first_indexed | 2024-04-14T06:46:27Z |
format | Article |
id | doaj.art-54c39d08077b41e3b9cc0c25c419d8fc |
institution | Directory Open Access Journal |
issn | 1080-6040 1080-6059 |
language | English |
last_indexed | 2024-04-14T06:46:27Z |
publishDate | 2020-03-01 |
publisher | Centers for Disease Control and Prevention |
record_format | Article |
series | Emerging Infectious Diseases |
spelling | doaj.art-54c39d08077b41e3b9cc0c25c419d8fc2022-12-22T02:07:09ZengCenters for Disease Control and PreventionEmerging Infectious Diseases1080-60401080-60592020-03-0126361962110.3201/eid2603.190798Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017Kaitlin BenedictOrion Z. McCotterBrendan R. JacksonCoccidioidomycosis skin testing appears to be uncommon, based on US health insurance claims data. Patient demographic features were consistent with the approval of the test for adults, but few patients had previous coccidioidomycosis diagnosis codes supporting its use for detecting delayed-type hypersensitivity in those with a history of pulmonary coccidioidomycosis.https://wwwnc.cdc.gov/eid/article/26/3/19-0798_articlecoccidioidomycosisskin testsUnited Stateshealth insurancerespiratory infectionsCoccidioides |
spellingShingle | Kaitlin Benedict Orion Z. McCotter Brendan R. Jackson Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017 Emerging Infectious Diseases coccidioidomycosis skin tests United States health insurance respiratory infections Coccidioides |
title | Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017 |
title_full | Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017 |
title_fullStr | Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017 |
title_full_unstemmed | Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017 |
title_short | Coccidioidomycosis Skin Testing in a Commercially Insured Population, United States, 2014–2017 |
title_sort | coccidioidomycosis skin testing in a commercially insured population united states 2014 2017 |
topic | coccidioidomycosis skin tests United States health insurance respiratory infections Coccidioides |
url | https://wwwnc.cdc.gov/eid/article/26/3/19-0798_article |
work_keys_str_mv | AT kaitlinbenedict coccidioidomycosisskintestinginacommerciallyinsuredpopulationunitedstates20142017 AT orionzmccotter coccidioidomycosisskintestinginacommerciallyinsuredpopulationunitedstates20142017 AT brendanrjackson coccidioidomycosisskintestinginacommerciallyinsuredpopulationunitedstates20142017 |